---
title: The German sickle cell disease registry reveals a surprising risk of acute
  splenic sequestration and an increased transfusion requirement in patients with
  compound heterozygous sickle cell disease HbS/β-thalassaemia and no or low HbA expression
date: '2024-07-01'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38946051/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240701183438&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'Patients with sickle cell disease (SCD) in Germany exhibit a substantial
  genetic diversity in the β-globin genotype. Data collected by the national German
  SCD registry reflect this diversity and allowed us to analyze the phenotypes associated
  with different SCD genotypes. Our study focused on 90 patients with HbS/β-thalassaemia
  (HbS/β-thal) and compared these to patients with HbSS and HbSC. Patients with HbS/β-thal
  were classified into three groups: HbS/β⁰-thal (no HbA), HbS/β^(+)-thal (HbA ...'
disable_comments: true
---
Patients with sickle cell disease (SCD) in Germany exhibit a substantial genetic diversity in the β-globin genotype. Data collected by the national German SCD registry reflect this diversity and allowed us to analyze the phenotypes associated with different SCD genotypes. Our study focused on 90 patients with HbS/β-thalassaemia (HbS/β-thal) and compared these to patients with HbSS and HbSC. Patients with HbS/β-thal were classified into three groups: HbS/β⁰-thal (no HbA), HbS/β^(+)-thal (HbA ...